Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 1:11:602477.
doi: 10.3389/fendo.2020.602477. eCollection 2020.

Genetics and Epigenetics: New Insight on Gestational Diabetes Mellitus

Maria Grazia Dalfrà  1 , Silvia Burlina  1 , Gloria Giovanna Del Vescovo  1 , Annunziata Lapolla  1
Affiliations
Review

Genetics and Epigenetics: New Insight on Gestational Diabetes Mellitus

Maria Grazia Dalfrà et al. Front Endocrinol (Lausanne). .

Abstract

Gestational diabetes mellitus (GDM) is the most common metabolic complication of pregnancy, with a prevalence that has increased significantly in the last decade, coming to affect 12-18% of all pregnancies. GDM is believed to be the result of a combination of genetic, epigenetic and environmental factors. Following the identification of susceptibility genes for type 2 diabetes by means of genome-wide association studies, an association has also been demonstrated between some type 2 diabetes susceptibility genes and GDM, suggesting a partial similarity of the genetic architecture behind the two forms of diabetes. More recent genome-wide association studies, focusing on maternal metabolism during pregnancy, have demonstrated an overlap in the genes associated with metabolic traits in gravid and non-gravid populations, as well as in genes apparently unique to pregnancy. Epigenetic changes-such as DNA methylation, histone modifications and microRNA gene silencing-have also been identified in GDM patients. Metabolomics has been used to profile the metabolic state of women during pregnancy, based on the measurement of numerous low-molecular-weight metabolites. Measuring amino acids and conventional metabolites has revealed changes in pregnant women with a higher insulin resistance and high blood glucose levels that resemble the changes seen in non-gravid, insulin-resistant populations. This would suggest similarities in the metabolic profiles typical of insulin resistance and hyperglycemia whether individuals are pregnant or not. Future studies combining data obtained using multiple technologies will enable an integrated systems biology approach to maternal metabolism during a pregnancy complicated by GDM. This review highlights the recent knowledge on the impact of genetics and epigenetics in the pathophysiology of GDM and the maternal and fetal complications associated with this pathology condition.

Keywords: epigenetic; genetic; gestational diabetes; mass spectrometry; nutrition; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Postulated effect of fetal nutrition in utero on hypothalamus central regulator of obesity programming and subsequent risk later in life.
Figure 2
Figure 2
Obesity and high fat diet in pregnancy: impact on fetus development and adverse health outcomes in adult later in life.
See this image and copyright information in PMC

References

    1. International Association of Diabetes and Pregnancy Study Groups Consensus Panel International Association of Diabetes and Pregnancy Study Groups: Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care (2010) 33:676–68. 10.2337/dc09-1848 - DOI - PMC - PubMed
    1. Koning SH, Hoogenberg K, Lutgers HL, Van den Berg PP, Wolffenbuttel BHR. Gestational diabetes mellitus: current knowledge and unmet needs. J Diabetes (2016) 8(6):770–81. 10.1111/1753-0407.12422 - DOI - PubMed
    1. Lapolla A, Metzger BE. The post-HAPO situation with gestational diabetes: the bright and dark sides. Acta Diabetol (2018) 55(9):885–92. 10.1007/s00592-018-1146-7 - DOI - PubMed
    1. McIntyre DH, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev (2019) 5:1–19. 10.1038/s41572-019-0098-8 - DOI - PubMed
    1. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab (1988) 67:341–47. 10.1210/jcem-67-2-341 - DOI - PubMed

Substances